Completed PHASE4 INTERVENTIONAL 1-arm NCT00450775

Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars

Sponsor: Innovative Medical

Conditions Scars

Interventions Dermatix Q

Updated 5 times since 2017 Last updated: Sep 23, 2008 Started: Mar 31, 2007 Primary completion: Mar 31, 2008 Completion: Mar 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Scars, this trial is completed. The trial is conducted by Innovative Medical and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Innovative Medical

Data source: Innovative Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Coral Gables, United States